PERSISTENT NEONATAL MICROTHROMBOCYTOPENIA: THE ROLE OF COMPLETE BLOOD COUNT AND PERIPHERAL BLOOD SMEAR IN DIAGNOSTIC EVALUATION
DOI:
https://doi.org/10.24197/py8bh976Keywords:
WISKOTT–ALDRICH SYNDROME; NEONATAL THROMBOCYTOPENIA; MICROPLATELETS; PRIMARY IMMUNODEFICIENCY; GENE THERAPYAbstract
Introduction
Neonatal thrombocytopenia is a frequent reason for evaluation in Neonatology and Pediatric Hematology, with a broad differential diagnosis that includes acquired causes, infectious, immunological and hereditary.
Clinical case
We report the case of a male neonate presenting with severe thrombocytopenia and generalized petechiae within the first hours of life. Initial evaluation suggested neonatal alloimmune thrombocytopenia, although immunohematological studies were inconclusive. Peripheral blood smear demonstrated persistent microthrombocytopenia, orienting the differential diagnosis toward inherited X-linked thrombocytopenias. Genetic testing identified the pathogenic hemizygous variant c.961C>T; p.Arg321Ter in the WAS gene, confirming Wiskott–Aldrich syndrome. Wiskott–Aldrich syndrome (WAS) is an X-linked primary immunodeficiency characterized by microthrombocytopenia, eczema, and combined immunodeficiency. The patient required platelet transfusions, intravenous immunoglobulin replacement, and anti-infective prophylaxis, and was eventually accepted for gene therapy.
Conclusions
Persistent microthrombocytopenia in a male infant should raise suspicion for Wiskott–Aldrich syndrome even in the absence of eczema or recurrent infections. Platelet morphological assessment remains an essential diagnostic tool in neonatal thrombocytopenia.
Downloads
References
1. Stanworth SJ, Mumford AD. How I diagnose and treat neonatal thrombocytopenia. Blood. 2023;141(22):2685-2697. doi:10.1182/blood.2022018017.
2. Peterson JA, McFarland JG, Curtis BR, Aster RH. Neonatal alloimmune thrombocytopenia: pathogenesis, diagnosis and management. Br J Haematol. 2013;161(1):3-14. doi:10.1111/bjh.12235.
3. Perez Botero J, Di Paola J. Diagnostic approach to the patient with a suspected inherited platelet disorder: who and how to test. J Thromb Haemost. 2021;19(9):2127-2136. doi:10.1111/jth.15484.
4. Noris P, Pecci A. Hereditary thrombocytopenias: a growing list of disorders. Hematology Am Soc Hematol Educ Program. 2017;2017(1):385-399. doi:10.1182/asheducation-2017.1.385.
5. Ochs HD, Thrasher AJ. The Wiskott-Aldrich syndrome. J Allergy Clin Immunol. 2006;117(4):725-738. doi:10.1016/j.jaci.2006.02.005.
6. Candotti F. Clinical manifestations and pathophysiological mechanisms of the Wiskott-Aldrich syndrome. J Clin Immunol. 2018;38(1):13-27. doi:10.1007/s10875-017-0453-z.
7. Vallée TC, Glasmacher JS, Buchner H, et al. Wiskott-Aldrich syndrome: a study of 577 patients defines the genotype as a biomarker for disease severity and survival. Blood. 2024;143(24):2504-2516. doi:10.1182/blood.2023021411.
8. Rivers E, Worth A, Thrasher AJ, Burns SO. How I manage patients with Wiskott Aldrich syndrome. Br J Haematol. 2019;185(4):647-655. doi:10.1111/bjh.15831.
Downloads
Published
Issue
Section
License
Copyright (c) 2026 MARTA HERNANDEZ

This work is licensed under a Creative Commons Attribution 4.0 International License.
The articles published at Clínica will have a Creative Commons Attribution 4.0 International License (CC BY 4.0).
The journal allows the authors to retain publishing rights. Authors may reprint their articles in other media without having to request authorization, provided they indicate that the article was originally published in Clínica.
